Canada Pension Plan Investment Board’s Takeda Pharmaceutical TAK Stock Holding History

Canada Pension Plan Investment Board’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10	Closed	–	–	1556
2021 Q4	$0	Hold	10	–	–	﹤0.01%	1612
2021 Q3	$0	Hold	10	–	–	﹤0.01%	1468
2021 Q2	$0	Sell	10 -57,780	-100%	-$984K	﹤0.01%	1351
2021 Q1	$1.05M	Sell	57,790 -302,600	-84%	-$5.44M	﹤0.01%	991
2020 Q4	$6.56M	Buy	360,390 +126,500	+54%	+$2.22M	0.01%	569
2020 Q3	$4.17M	Hold	233,890	–	–	0.01%	531
2020 Q2	$4.19M	Buy	+233,890	New	+$4.2M	0.01%	566
2019 Q2	–	Sell	-71,316	Closed	-$1.45M	–	1466
2019 Q1	$1.45M	Buy	+71,316	New	+$1.44M	﹤0.01%	1051

Other funds holding TAK

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Canada Pension Plan Investment Board's TAK Position: Q1 2022 in Review

Canada Pension Plan Investment Board sold out of Takeda Pharmaceutical (TAK) in Q1 2022, closing a stake of 10 shares.

Canada Pension Plan Investment Board first reported a position in TAK in Q1 2019 and held it in 8 quarters. The position peaked at $6.56M in Q4 2020. 288 funds tracked by Wall St. Rank hold TAK as of Q1 2022.

Canada Pension Plan Investment Board reported no remaining Takeda Pharmaceutical position as of Q1 2022 after selling out during the quarter.
Canada Pension Plan Investment Board sold 10 Takeda Pharmaceutical shares in Q1 2022.
Canada Pension Plan Investment Board first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 8 quarters.
Canada Pension Plan Investment Board's Takeda Pharmaceutical position peaked at $6.56M in Q4 2020.
288 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2022.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2022, filed 13 May 2022.